Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2317-2319

  Ringwald, Pascal ^a,b,d   Bickii, Jean ^b   Same Ekobo, Albert ^c   Basco, Leonardo K ^a,b  

^a Inst Francais Rech Sci pour le D   (Cameroon)

^b Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; PYRONARIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DATA ANALYSIS; DRUG DETERMINATION; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; MALARIA; ORAL DRUG ADMINISTRATION; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0030827240     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2317     Document Type: Article

References (12)

1. Baird, J. K., H. Basri, B. Subianto, D. J. Fryauff, P. D. McElroy, B. Leksana, T. L. Richie, S. Masbar, F. S. Wignall, and S. L. Hoffman. 1995. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J. Infect. Dis. 171:1678-1682.
2. Basco, L. K., and J. Le Bras. 1994. Short-term in vitro culture of Plasmodium vivax and P. ovale for drug susceptibility testing. Parasitol. Res. 80:262-264.
3. Chen, C., L. H. Tang, and C. Jantanavivat. 1992. Studies on a new antimalarial compound: pyronaridine. Trans. R. Soc. Trop. Med. Hyg. 86:7-10.
4. Fu, S., and S. H. Xiao. 1991. Pyronaridine: a new antimalarial drug. Parasitol. Today 7:310-313.
5. Looareesuwan, S., D. E. Kyle, C. Viravan, S. Vanijanonta, P. Wilairatana, and W. H. Wernsdorfer. 1996. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 54:205-209.
6. Mount D. L., B. L. Nahlen, L. C. Patchen, and F. C. Churchill. 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull. W. H. O. 67:295-300.
7. Olliaro, P. L., and P. I. Trigg. 1995. Status of antimalarial drugs under development. Bull. W. H. O. 73:565-571.
8. Peters, W. 1987. Chemotherapy and drug resistance in malaria, 2nd ed. Academic Press, London, England.
9. Ringwald, P., J. Bickii, and L. Basco. 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347:24-28.
10. Ringwald, P., J. Bickii, and L. K. Basco. 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am. J. Trop. Med. Hyg. 55:254-258.
11. Tan-ariya, P., and S. Pasuralertsakul. 1994. First report on in vitro susceptibility of Plasmodium malariae Thai isolates to chloroquine. Southeast Asian J. Trop. Med. Public Health 25:784-787.
12. World Health Organization, Division of Control of Tropical Diseases. 1994. Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. WHO/MAL/94.1070.